EQS-News: CEVEC Pharmaceuticals GmbH / Key word(s): Agreement CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing 20.09.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. ROKOTE Laboratories licen.
CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories Licenses CEVEC s CAP(R) Ad Technology for Vaccine Manufacturing theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
DGAP-News: CEVEC Pharmaceuticals GmbH / Key word(s): Miscellaneous CEVEC's license partner RZNOMICS Inc. receives approval to initiate clinical development of CAP Ad Technology-produced gene
DGAP-News: CEVEC Pharmaceuticals GmbH / Key word(s): Miscellaneous CEVEC’s license partner RZNOMICS Inc. receives approval to initiate clinical development of CAP® Ad Technology-produced gene therapy vector in liver cancer patients 13.07.2022 / 14:00 The issuer is solely responsible for the cont.